Pacific Biosciences (PACB) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, with virtual attendance available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 2, 2026.

Voting matters and shareholder proposals

• Election of six directors: William Ericson, Chris Gibson, Ph.D., Christian O. Henry, John F. Mulligan, Ph.D., Kathy Ordoñez, and Christopher M. Smith.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve compensation of named executive officers.

• Approval of amendment to the 2020 Equity Incentive Plan.

• Proxies may vote on other business arising at the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.